China says it does not want a trade war with US China does not want a trade war w ith the United States but will defend its interests, a senior Chinese diplomat said on Sunday. Won't sit by and watch as China's interests are damaged-minister Trump last week unveiled plan for import duties on steel, aluminium.

U.S. Aircraft Carrier Arrives in Vietnam, With a Message for China BANGKOK — For the first time since the end of the Vietnam War, a United States aircraft carrier made a port call in Vietnam on Monday, signaling how China’s rise is bringing together former foes in a significant shift in the region’s geopolitical landscape.

Survivors of Lung Cancer Suffers Fatigue, Poor Quality of Life A new study has revealed lung cancer survivors face significant hardships due to chronic fatigue.

California Falls Short In Early Diagnosis Of Lung Cancer California needs to up its game in the fight against lung cancer, according to a new report from the American Lung Association .

Key Statistics for Lung Cancer How common is lung cancer? Lung cancer (both small cell and non-small cell) is the second most common cancer in both men and women (not counting  skin cancer ). In men,  prostate cancer  is more common, while in women  breast cancer  is more common. About 14% of all new cancers are lung cancers. The American Cancer Society’s estimates for lung cancer in the United States for 2018 are: -  About 234,030 new cases of lung cancer (121,680 in men and 112,350 in women)   About 154,050 deaths from lung cancer (83,550 in men and 70,500 in women) Lung cancer is by far the leading cause of cancer death among both men and women Each year, more people die of lung cancer than of  colon , breast, and prostate cancers combined. Lung cancer mainly occurs in older people. Most people diagnosed with lung cancer are 65 or older, while a very small number of people diagnosed younger than 45. The average age at the time of diagnosis is about 70. Lifetime cha

HEALTH: Immunotherapy - Beyond Melanoma and Lung Cancer Treatment In the late 1800s, William Coley, a surgeon in New York, developed what scientists now think was the first cancer immunotherapy.

Brakes off in effort to confront melanoma